RECORMON 5000 IU Price

Overview

Welcome to Dwaey, specifically on RECORMON 5000 IU Injection page.
This medicine contains an important and useful components, as it consists of Epoetin beta.
RECORMON 5000 IU is available in the market in concentration 5000 IU/Vial and in the form of Injection.

F. HOFFMANN-LA ROCHE LTD. is the producer of RECORMON 5000 IU and it is imported from SWITZERLAND, The most popular alternatives of RECORMON 5000 IU are listed downward .

Mode Of Action

Epoetin beta stimulates RBC production in the bone marrows which transmits O2 through out the body.

Indication

• Anaemia of chronic renal failure
• Anaemia in zidovudine-treated HIV-infected patients
• Anemia related to non-myeloid malignant disease chemotherapy
• To reduce the need for allogenic blood tranfusion
• Anaemia of prematurity.

Precaution

Hypertension, history of seizure, thrombocytosis, chronic hepatic impairment, ischaemic vascular disease, malignant tumours, epilepsy; recent MI or CVA. Fe deficiency, infection, inflammatory disorders, haemolysis and aluminium intoxication may decrease response to epoetin beta. Regularly monitor platelet counts and serum-potassium concentrations. Control haematocrit levels. Poorly-controlled hypertension: Monitor BP, Hb and electrolytes. Anaemia (eg, megaloblastic or folic acid): Give Fe supplements when needed. Thromobocytosis: monitor platelet count for 1st 8 wk. Lactation. Lactation: not known if excreted in breast milk, use caution

Side Effects

• >10% Hypertension (13%)
• Diarrhea (11%)
• Nasopharyngitis (11%) 1-10% Headache (9%)
• Upper respiratory tract infection (9%)
• Cough (6%)
• Hypotension (5%)
• Urinary tract infection (5%)
• Procedural arteriovenous fistula thrombosis (5%) Frequency Not Defined Coronary artery disease
• Anemia
• Septic shock
• Serious cardiovascular and thromboembolic events
• Seizures
• Immunogenicity related PRCA
• Increased mortality and/or tumor progression in cancer patients
• Increased mortality
• Concomitant termination of other CRF therapy
• Stevens-Johnson syndrome
• Toxic epidermal necrolysis

Contra indication

Uncontrolled hypertension. Neonates: injections containing benzyl alcohol.

Pregnancy and lactation

Pregnancy category: C

Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks